Skeletal Muscle Index And Ovarian Cancer Prognosis: A Meta-Analysis Overview In this study, a meta-analysis was carried out to determine the correlation between low skeletal muscle index (SMI) and the clinicopathological features and prognosis of patients with ovarian cancer. Advances in the ability to predict the overall survival rate and prognosis of ovarian
Tag: oncologist
Pediatric Oncology: Diagnosis And Prognosis Communication
Pediatric Oncology: Diagnosis And Prognosis Communication Overview When a child is diagnosed with cancer, it is an incredibly difficult situation for everyone in the family, and the parents especially have a hard time understanding the complicated details of the diagnosis and outcome. They usually want doctors to be honest and transparent, though
Carfilzomib Therapy in Pediatric Acute Lymphoblastic Leukemia
Carfilzomib Therapy in Pediatric Acute Lymphoblastic Leukemia Overview In this study, the safety and tolerability of a combination of carfilzomib and vincristine, dexamethasone, asparaginase, and daunorubicin (VXLD) were assessed in children with relapsed and/or refractory acute lymphoblastic leukemia (ALL). ALL is the most common cancer diagnosed in childhood and survival for patients
Medullary Thyroid Cancer and Vocal Cord Paralysis
Medullary Thyroid Cancer and vocal cord paralysis Overview Medullary thyroid cancer (MTC) is a rare form of thyroid cancer that affects only 3-5% of all thyroid cancer cases in the United States. While the prognosis for MTC is generally good, there is a chance of vocal cord paralysis (VCP) due to the
primary adenocarcinoma of the orbit: a case study
primary adenocarcinoma of the orbit: a case study Introduction Primary mucinous adenocarcinoma is an anomalous neoplasm with a tendency to frequently recur and metastasize. It is a rare neoplasm with no predisposing factors or etiology. It can often be seen throughout the body, especially in the head or neck. Symptoms include abdominal
Survival trends: pancreatic cancer in the USA
survival trends: pancreatic cancer in the USA STUDY BACKGROUND Pancreatic cancer (PC) is a devastating malignancy with a 5-year survival rate of 10%. Despite accounting for only 3% of all new cancer diagnoses, it is the third leading cause of cancer-related deaths in the US. Surgical resection is the only potentially curative
Remission of Renal Cell Carcinoma With Brain Metastases: A Case Study
Remission of Renal Cell Carcinoma With Brain Metastases: A Case Study Cases of complete remission of cancers with brain metastases are very rare. It’s often brought by tyrosine kinase inhibitor monotherapy in patients with metastatic renal cell carcinoma. For metastatic renal cell carcinoma (mRCC) patients, the case of brain metastasis has been
Colorectal Cancer Screening for Older Adults
Colorectal Cancer Screening for Older Adults Overview of the Study Colorectal cancer (CRC) is the second most deadly cancer worldwide. As such, the need for resilient colorectal cancer screening (CRCS) is increasingly becoming more important to reduce complications due to delays in care. However, the realistic participation target remains unelucidated. This research aims
Hearing Screening After Chemotherapy: A Study On Childhood Cancer Survivors
Hearing Screening After Chemotherapy: A Study On Childhood Cancer Survivors The Study Background The survival rates of children with cancer have increased steadily since the mid-1970s, from 58% to 85% in developed countries. However, these improvements are tainted by immediate and late effects of treatment. Geenen et al. and Oeffinger et al.
Prostate Cancer: A New Biopsy Risk Calculator using MRI
Prostate Cancer: A New Biopsy Risk Calculator using MRI Study Background In men, prostate cancer (PCa) is the most commonly diagnosed malignancy in over 50% of countries. Despite this statistic, a large number of prostate cancer cases are not clinically significant and are unlikely to lead to problems if left untreated. Differentiating
